The company Quality Management System, with ISO 13485 certification, and the CE certifications of the medical devices marketed in compliance with Directive 93/42/EEC ensure product compliance with compulsory requirements, due process monitoring and the constant analysis of process efficiency and effectiveness. Strict quality controls are carried out throughout the production process, including acceptance tests, line tests and end quality tests. These controls are carried out on the basis of a sampling plan in compliance with standard UNI ISO 2859, using suitable instruments and operating instructions supplied to the Q.C. service.

The Bioservice Group is aware of the importance of quality as fundamental to business growth and as an added value that can enable the group to stand out from its competitors and characterise its products not just in developed countries but also in emerging countries. Therefore Bioservice has a continuous commitment to making improvements, supported by its invaluable customer feedback and constructive use of the complaints system.

Rev. 03  7/09/2007